ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 19 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $365,000 | -89.6% | 364,000 | -89.5% | 0.00% | – |
Q2 2021 | $3,495,000 | +39.5% | 3,480,000 | +40.7% | 0.00% | – |
Q1 2021 | $2,506,000 | -27.2% | 2,474,000 | -22.0% | 0.00% | -100.0% |
Q4 2020 | $3,443,000 | -40.5% | 3,171,000 | -42.9% | 0.00% | 0.0% |
Q3 2020 | $5,789,000 | +45.0% | 5,557,000 | +53.2% | 0.00% | 0.0% |
Q2 2020 | $3,993,000 | +18.4% | 3,628,000 | +10.2% | 0.00% | 0.0% |
Q1 2020 | $3,372,000 | +110.8% | 3,293,000 | +135.7% | 0.00% | – |
Q4 2019 | $1,600,000 | -64.4% | 1,397,000 | -64.6% | 0.00% | -100.0% |
Q3 2019 | $4,498,000 | -61.1% | 3,949,000 | -59.5% | 0.00% | -66.7% |
Q2 2019 | $11,563,000 | -22.6% | 9,741,000 | -11.9% | 0.00% | -25.0% |
Q1 2019 | $14,934,000 | +5.3% | 11,057,000 | -16.4% | 0.00% | 0.0% |
Q4 2018 | $14,189,000 | +30.6% | 13,226,000 | +28.4% | 0.00% | +33.3% |
Q3 2018 | $10,861,000 | +40.9% | 10,300,000 | +30.9% | 0.00% | +50.0% |
Q2 2018 | $7,710,000 | -1.0% | 7,869,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,788,000 | -6.0% | 7,869,000 | +0.1% | 0.00% | 0.0% |
Q4 2017 | $8,285,000 | +0.1% | 7,859,000 | +0.0% | 0.00% | 0.0% |
Q3 2017 | $8,279,000 | +115.4% | 7,857,000 | +116.6% | 0.00% | +100.0% |
Q2 2017 | $3,844,000 | -14.5% | 3,627,000 | -22.8% | 0.00% | 0.0% |
Q1 2017 | $4,496,000 | -7.0% | 4,696,000 | -1.6% | 0.00% | 0.0% |
Q4 2016 | $4,834,000 | +23.9% | 4,774,000 | +13.7% | 0.00% | 0.0% |
Q3 2016 | $3,900,000 | -5.9% | 4,200,000 | -28.1% | 0.00% | 0.0% |
Q2 2016 | $4,145,000 | -43.3% | 5,839,000 | -27.2% | 0.00% | -66.7% |
Q1 2016 | $7,314,000 | -18.9% | 8,026,000 | +0.0% | 0.00% | 0.0% |
Q4 2015 | $9,018,000 | – | 8,025,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|